Theratechnologies EBITDA margin
What is the EBITDA margin of Theratechnologies?
The EBITDA margin of Theratechnologies, Inc. is -27.40%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Health Care sector on TSX compared to Theratechnologies
What does Theratechnologies do?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Companies with ebitda margin similar to Theratechnologies
- QYOU Media has EBITDA margin of -27.60%
- Appian has EBITDA margin of -27.58%
- FLYHT Aerospace Solutions has EBITDA margin of -27.53%
- Axion Ventures has EBITDA margin of -27.49%
- Tejas Networks has EBITDA margin of -27.41%
- SiTime Corp has EBITDA margin of -27.41%
- Theratechnologies has EBITDA margin of -27.40%
- China Shenghai Food has EBITDA margin of -27.31%
- Immunogen has EBITDA margin of -27.28%
- ARSS Infrastructure Projects has EBITDA margin of -27.27%
- QuickLogic has EBITDA margin of -27.23%
- Accel Transmatic has EBITDA margin of -27.21%
- Sanara MedTech has EBITDA margin of -27.20%